These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer. Ishida A, Miyazawa T, Miyazu Y, Iwamoto Y, Zaima M, Kanoh K, Sumiyoshi H, Doi M. Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208 [Abstract] [Full Text] [Related]
5. Modified intrapleural cisplatin treatment for lung cancer with positive pleural lavage cytology or malignant effusion. Muraoka M, Oka T, Akamine S, Tagawa T, Morinaga M, Inoue M, Yamayoshi T, Hashizume S, Matsumoto K, Hayashi T, Nagayasu T. J Surg Oncol; 2006 Mar 15; 93(4):323-9. PubMed ID: 16496367 [Abstract] [Full Text] [Related]
7. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. Perez-Soler R, Shin DM, Siddik ZH, Murphy WK, Huber M, Lee SJ, Khokhar AR, Hong WK. Clin Cancer Res; 1997 Mar 15; 3(3):373-9. PubMed ID: 9815694 [Abstract] [Full Text] [Related]
8. [Results of hypotonic cisplatin treatment on seven patients with carcinomatous pleuritis]. Tsubouchi H, Tokuda K, Shimana A, Fukushima K. Gan To Kagaku Ryoho; 2006 Nov 15; 33(11):1629-32. PubMed ID: 17108730 [Abstract] [Full Text] [Related]
9. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515. Yoshida K, Sugiura T, Takifuji N, Kawahara M, Matsui K, Kudoh S, Takada M, Fukuoka M, Ariyoshi Y, Fukuda H, Saijo N. Lung Cancer; 2007 Dec 15; 58(3):362-8. PubMed ID: 17716779 [Abstract] [Full Text] [Related]
11. [Clinical evaluation of the combination treatment of intrapleural or intraperitoneal administration of lentinan and OK-432 for malignant effusion]. Yoshino S, Yoshida S, Maeda N, Maeda Y, Maeda K, Hazama S, Oka M. Gan To Kagaku Ryoho; 2010 Nov 15; 37(12):2798-800. PubMed ID: 21224717 [Abstract] [Full Text] [Related]
12. [Adhesion therapy for malignant pleural effusion (intrapleural administration of OK-432 with minocycline)]. Tanaka A, Sato T. Nihon Kokyuki Gakkai Zasshi; 1999 Jul 15; 37(7):531-7. PubMed ID: 10481458 [Abstract] [Full Text] [Related]
13. [Clinical evaluation of intrapleural or peritoneal repetitive administration of Lentinan and OK-432 for malignant effusion]. Kawaoka T, Yoshino S, Kondo H, Yamamoto K, Hazama S, Oka M. Gan To Kagaku Ryoho; 2005 Oct 15; 32(11):1565-7. PubMed ID: 16315870 [Abstract] [Full Text] [Related]
17. [Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period]. Kan N. Gan To Kagaku Ryoho; 1999 Oct 15; 26(12):1796-800. PubMed ID: 10560397 [Abstract] [Full Text] [Related]
20. [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion]. Fukuoka M, Takada M, Tamai S, Negoro S, Matsui K, Ryu S, Sakai N, Sakaguchi K. Gan To Kagaku Ryoho; 1984 Aug 15; 11(8):1543-9. PubMed ID: 6206796 [Abstract] [Full Text] [Related] Page: [Next] [New Search]